Detailed Agenda 2018

Please click on arrow (left of each item) to display activities for the day

  • + -

    Thursday, November 1, 2018

    9:00 AM- 12:00 AM

    CNS Summit 2018 Leadership Council Meeting
    -- Members of Leadership Council Only --

    12:00 PM- 2:00 PM

    Lunch
    -- On Own --

    2:00 PM- 3:00 PM

    Women in Leadership: Enhancing Success and Culture in Life Sciences
    The CNS Summit Community has always had an emphasis on cultural change and diversity of perspectives and thought. We are excited to have a formal session on how women leaders have succeeded, what lessons they have learned, and what remains to be done. This will be an interactive session where all participants can discuss this important topic.
              Alexandria Wise-Rankovic, Senior Vice President, CNS Clinical Development, Syneos Health
              Jane Metcalfe, Founder, Neo.life, Co-Founder, WIRED
              Georgia Mitsi, Digital Healthcare, Sunovion
              Stacey Boyer, Vice President, Clinical Research Operations, Cavion
              Irena Webster, Director, Clinical Development, Sage Therapeutics
              Charles Wilcox, Executive Director, Pharmacology Research Institute
              Chair: Shishuka Malhotra, Founder & Medical Director, Neuro-Behavioral Clinical Research


    3:30 PM- 4:30 PM

    SPECIAL RECEPTION
    -- By Invitation Only --

    4:30 PM- 5:00 PM

    CNS Summit 2018 New Participant Reception

    5:00 pm- 6:30 pm

    CNS Summit 2018 Welcome Reception
    -- Everyone Welcome! --
  • + -

    Friday, November 2, 2018

    7:00 AM- 7:45 AM

    Breakfast

    8:00 AM- 12:00 PM

    Welcome Remarks

    Introductory Address
    Amir Kalali, Chief Curator, CNS Summit

    CNS Summit 2018 Keynote Session
    Mary Lou Jepsen, Founder & CEO, Openwater
    Myrtle Potter, Vant Operating Chair, Roivant Sciences
    Eric Perakslis, Chief Science Officer, Datavant
    Peter Bergethon, Head, Quantitative Medicine & Clinical Technologies, Biogen
    Doug Schantz, Executive Director, Clinical Operations, AstraZeneca
    Benjamine Liu, CEO, TrialSpark
    Jacob LaPorte, Global Head, Digital Development, Novartis
    Joris Van Dam, Head of Digital Therapeutics, Novartis
    Jeremy Sohn, VP, Global Head of Digital Business Development & Licensing, Novartis
    Yuri Maricich, Chief Medical Officer & Head of Clinical Development, Pear Therapeutics
    Ed Ikeguchi, Chief Medical Officer, AiCure
    Megan Jones Bell, Chief Science Officer, Headspace
    Richie Etwaru, Founder & CEO, Hu-manity.co


    CNS Summit 2018 Innovation Index
    Top 10 Pharma Awardees of 2018 Innovation Index
    Presented by Amir Kalali, Chief Curator, CNS Summit & Mike Rea, CEO, IDEA Pharma


    12:00 pm- 1:00 pm

    Innovation Showcase
    (Lunch Provided)
    Katharina Volz, CEO & Founder, OccamzRazor
    Benjamin Vandendriessche, Chief Medical Officer, Byteflies
    Chelsea Trengrove, Program Manager, Empatica
    Ardy Arianpour, Co-Founder & CEO, Seqster
    Mouli Narayanan, Founder & CEO, Zeblok
    Joydeep Sarkar, Chief Analytics Officer, Holmusk
    Moderated By Spyros Papapetropoulos, Cavion and Georgia Mitsi, Sunovion

    1:00 pm- 1:30 pm

    Solution Showcase
    Chris Benko, CEO, Koneksa Health
    Robert Ellis, CTO, Koneksa Health


    1:45 pm- 3:15 pm

    CNS Summit Parallel Sessions:

    Session 1: Neuroscience
              Emiliangelo Ratti, Senior Vice President, Global Head, Neuroscience, Takeda "Neuroscience at Takeda"
              Kenneth Koblan, Head of Discovery and Global TMED, Sunovion
              Karoly Nikolich, CEO, Alkahest
              Phil Harvey, Leonard M. Miller Professor of Psychiatry & Behavioral Sciences, University of Miami Miller School of Medicine
              Alex Cohen, Louisiana State University
              Gregory Strauss, University of Georgia
              Co-Chair: Atul Mahableshwarkar, VP Clinical Development, BlackThorn Therapeutics
              Co-Chair: Roger Bullock, Chief Medical Officer, Oryzon Genomics

    Session 2: Should Pharma Care about Digital Therapeutics?
              Yuri Maricich, CMO & Head, Clinical Development, Pear Therapeutics
              Mohammed Ali, Global Head, Digital Trials, Boehringer Ingelheim Pharmaceuticals
              Pravin Jadhav, R&D Innovation, Otsuka
              Chair: Ed Cox, CEO, DThera Sciences

    Session 3: Commercializing Innovation / Commercial Innovations
              Daniel Levine, Director, Avant-Guide Institute
              Peter Bach, Director, BioPharmaLogic
              Luca Pani, VeraSci and University of Miami Miller School of Medicine
              Yuri Maricich, CMO & Head, Clinical Development, Pear Therapeutics
              Robert Baurys, CEO, 83Bar
              Melinda Decker, Former Head of Oncology & Immuno-Oncology, AstraZeneca
              Don Apruzzese, CCO, Atentiv
              Andrew Wright, Otuska
              Co-Chair: Mike Rea, CEO, IDEA Pharma
              Co-Chair: Kate Hermans, Founder & CEO, Hermans International

    Session 4: Virtual Trials
              John Reites, Chief Product Officer, THREAD
              Tomasz Sablinski, Co-Founder & CEO, Transparency Life Sciences
              Adam Butler, Senior Vice President, Bracket
              Noah Craft, Co-Founder & CEO, Science 37
              Chair: Joe Dustin, Director, Mobile Health, Medidata

    Session 5: Redefining Health Data in the Digital Era: Introducing the Digitome
              Jake LaPorte, Global Head of Digital Development, Novartis
              Michelle Longmire, Co-Founder & CEO, Medable

    Session 6: How Can Sites Thrive in Changing Research Landscapes
              Irena Webster, Director, Clinical Development, Sage Therapeutics
              Brian Craig, CEO, Pillar Clinical Research
              Christian Burns, President, ClinEdge
              Shishuka Malhotra, Founder & Medical Director, Neuro-Behavioral Clinical Research
              Chair: Leslie Franceschi, Project Director, Syneos Health

    3:30 pm- 5:00 pm

    One-to-One Networking Sessions

    5:00 pm- 7:00 pm

    Evening Reception, Posters & Exhibits
  • + -

    Saturday, November 3, 2018

    7:00 AM- 7:45 AM

    Breakfast

    8:00 AM - 12:00 PM

    Welcome Remarks

    CNS Summit 2018 Keynote Session
    John Wilbanks, Chief Commons Officer, Sage Bionetworks
    Sara Holoubek, Founder & CEO, Luminary Labs
    Alistair Macdonald, CEO, Syneos Health
    Glen de Vries, President, Medidata Solutions
    Cynthia Verst, President, R&DS Design & Delivery Innovation, IQVIA
    Steven Rosenberg, SVP & General Manager Health Science, Oracle
    Mohammed Ali, Global Head, Digital Development, Boehringer Ingelheim
    Junaid Bajwa, Digital Centre of Excellence, Merck & Company
    Don Jones, Chief Digital Officer, Scripps Research Translational Institute
    Noah Craft, Co-Founder & CEO, Science 37
    Sharon Mates, CEO, Intra-Cellular Therapies
    Herriot Tabuteau, CEO, AXSOME Therapeutics
    Bakul Patel, Associate Director of Digital Health, FDA
    Jennifer Goldsack, Clinical Trials Transformation Initiative (CTTI)
    Joe Powers, Chief Strategy Officer, AppliedVR
    Rama Penta, Digital Health Innovation Group, Bayer
    Thomas Pianta, Inova Mount Vernon Hospital
    John Nosta, Founder, NostaLab
    Christopher Hadnagy, CEO, Social-Engineer
    Daniel Friedland, President & CEO, SuperSmart Health

    12:00 pm- 1:00 pm

    Innovation Showcase
    (Lunch Provided)
    Andy Coravos, Co-founder & CEO, Elektra Labs
    Ioannis Tarnanas, Chief Science Officer, Altoida
    Daniel Jones, Co-Founder & CEO, Aural Analytics
    Jonathan O'Keeffe, Co-Founder & CEO, Machine Medicine
    Jeannette Tsuei, Director of Strategic Alliances, AppliedVR
    Chris Wasden, Head of Pharma, Happify
    Moderated By Spyros Papapetropoulos, Cavion and Georgia Mitsi, Sunovion

    1:00 pm- 1:30 pm

    Solution Showcase
    Brian Craig, Founder & CEO, Pillar Clinical Research

    1:45 pm- 3:15 pm

    CNS Summit Parallel Sessions:

    Session 1: Neuroscience
              Harry Tracy, President, NI Research
              Carla Canuso, Senior Director, Clinical Development, Janssen
              Jaskaran Singh, Clinical Director, Neuroscience, Janssen
              Timothy Peters-Strickland, VP, Global Clinical Dev, CNS & Digital Medicine, Otsuka
              Spyros Papapetropoulos, EVP R&D & CMO, Cavion
              Jonathan Rubin, Chief Medical Officer, Atentiv
              Co-Chair: Adam Butler, Senior Vice President, Bracket
              Co-Chair: Atul Mahableshwarkar, VP Clinical Development, BlackThorn Therapeutics
              Co-Chair: Roger Bullock, Chief Medical Officer, Oryzon Genomics

    Session 2: Digital Therapeutics
              John P. Docherty, Vice President, Clinical Sciences, Digital Medicine, Otsuka America Pharmaceutical, Inc.
              Joris Van Dam, Strategic Projects Leader, Novartis

    Session 3: Commercializing Innovation / Commercial Innovations
              Michele Libonati, CEO, Proneurotech (former Roche)
              Jean-Jacques Bienaime, CEO, BioMarin
              Riju Khetarpal, Managing Director of Global Life Sciences, Box
              Alicyn Campbell, Genentech
              Mona Siddiqui, HHS
              Matt McNally, CEO, OutcomeHealth
              Co-Chair: Mike Rea, CEO, IDEA Pharma
              Co-Chair: Kate Hermans, Founder & CEO, Hermans International

    Session 4: Is Artificial Intelligence Poised to Transform the Pharmaceutical Industry?
              Joseph Owens, Project Manager Verily
              Iya Khalil, Chief Commercial Officer & Co-Founder, GNS Healthcare

    Session 5: Biopharma Trends: What Does the Future Hold?
              Leigh Householder, EVP/Managing Director, Insights & Innovation, Syneos Health
              Alexandria Wise-Rankovic, Senior Vice President, CNS Clinical Development, Syneos Health
              Dr. Stephen Brannan, Chief Medical Officer, Karuna Pharmaceuticals

    Session 6: Breaking Down Old Barriers: New Solutions to Using Mobile Technologies in Clinical Trials
              Bakul Patel, Associate Director for Digital Health, FDA
              Drew Schiller, Co-Founder & CEO, Validic
              Dan Karlin, Director of Biotech Ventures, CEAi
              Chair: Jennifer Goldsack, Clinical Project Manager, CTTI

    3:30 pm- 5:00 pm

    One-to-One Networking Sessions

    5:00 pm- 7:00 pm

    Evening Reception, Posters & Exhibits
  • + -

    Sunday, November 4, 2018

    8:00 am- 8:45 am

    Breakfast

    9:00 am- 12:00 pm

    Welcome Remarks

    CNS Summit 2018 Success Bootcamp

    Mindful Leadership to Optimize Professional and Personal Success
    Daniel Friedland, President & CEO, SuperSmart Health

    Using Improv Techniques to Develop Successful Collaborative Partnerships
    Stephanie Paul

    Reading Non-Verbal Cues to Enhance Success
    Christopher Hadnagy, CEO, Social-Engineer



    12:00 pm

    Adjourn